ABPI Calls for Urgent Steps to Boost UK Life Sciences Investment in Pre-Budget Submission
The Association of the British Pharmaceutical Industry (ABPI) has called on the government to take urgent action to reverse a decade-long decline in investment and restore the UK’s position as a global leader in life sciences.
Association Of The British Pharmaceutical Industry | 10/11/2025 | By Dineshwori | 164
UK Risks Losing Global Life Sciences Edge as Pharma Investment Decline, ABPI Warns
The UK risks losing its world-leading position in life sciences as investment in pharmaceutical research and development continues to fall behind international competitors, according to a new report from the Association of the British Pharmaceutical Industry (ABPI).
Association Of The British Pharmaceutical Industry | 12/09/2025 | By Dineshwori | 223
Pharma Leaders Back UK Life Sciences Strategy, But ABPI Warns of Medicines Investment Gap
Pharmaceutical and medical technology leaders, including GSK, Sandoz, Accord Healthcare, Becton Dickinson, and Celltrion have welcomed the UK government’s new Life Sciences Sector Plan, recently unveiled as part of its flagship Industrial Strategy.
Association Of The British Pharmaceutical Industry | 19/07/2025 | By Dineshwori | 160
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy